Results 11 to 20 of about 1,633 (196)

PIPAC for Gastrointestinal Malignancies

Journal of Clinical Medicine, 2023
The peritoneum is a common site of metastases for gastrointestinal tumors that predicts a poor outcome. In addition to decreased survival, peritoneal metastases (PMs) can significantly impact quality of life from the resulting ascites and bowel ...
Beatrice J. Sun, Byrne Lee, Sara K. Daniel   +2 more
core   +3 more sources

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma

BMC Cancer, 2018
Background Patients with recurrent malignant epithelioid mesothelioma (MM) after surgery and standard chemotherapy with cisplatin and pemetrexed have limited treatment options.
Urs Giger-Pabst, Cédric Demtröder, Thomas A. Falkenstein, Mehdi Ouaissi, Thorsten O. Götze, Günther A. Rezniczek, Clemens B. Tempfer   +6 more
doaj   +2 more sources

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries [PDF]

World Journal of Surgical Oncology, 2021
Background Peritoneal malignancies include primary and metastatic cancer of the peritoneal cavity. The most common origin for peritoneal metastasis is ovarian, gastric, and colorectal cancers.
Rokas Račkauskas, Augustinas Baušys, Martynas Lukšta, Jonas Jurgaitis, Marius Paškonis, Kęstutis Strupas   +5 more
doaj   +2 more sources

Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis [PDF]

Pleura and Peritoneum
Laparoscopic ultrasound (LUS) combines both laparoscopy and ultrasound imaging of the peritoneum liver and retroperitoneum. LUS has not been described in treatments with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Jørgensen Magnus S., Ainsworth Alan P., Fristrup Claus W., Mortensen Michael B., Graversen Martin   +4 more
doaj   +2 more sources

PIPAC Pharmacologic and Clinical Data

Journal of Surgical Oncology
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged as an innovative intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of systemic therapies to induce response in peritoneal malignancies.
Kranenburg, O., Yacoov, Almog Ben, Cortes-Guiral, Delia, Cortés-Guiral, D., Taibi, A., VAN DER SPEETEN, Kurt, Sgarbura, O., Van Der Speeten, K., Kranenburg, Onno, Sgarbura, Olivia, Taibi, Albdelkader, Hübner, M., Hubner, Martin, Yacoov, A.B.   +13 more
core   +6 more sources

Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery

Scientific Reports, 2023
Oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) is an emerging palliative treatment for patients with unresectable colorectal peritoneal metastases.
Vincent C. J. van de Vlasakker, Robin J. Lurvink, Emma C. Wassenaar, Paulien Rauwerdink, Checca Bakkers, Koen P. Rovers, Cynthia S. Bonhof, Jacobus W. A. Burger, Marinus J. Wiezer, Djamila Boerma, Simon W. Nienhuijs, Floortje Mols, Ignace H. J. T. de Hingh   +12 more
doaj   +2 more sources

Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) [PDF]

Pleura and Peritoneum
There are few data on Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in women with primary unresectable or recurrent platinum-resistant peritoneal metastasis (PM) from ovarian cancer (OC).
Foslund Ingrid Terese, von Magius Sahra Aisha Vinholt, Ainsworth Alan Patrick, Detlefsen Sönke, Fristrup Claus Wilki, Knudsen Anja Oer, Mortensen Michael Bau, Tarpgaard Line Schmidt, Jochumsen Kirsten Marie, Graversen Martin   +9 more
doaj   +2 more sources

Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study

Gastroenterology Research and Practice, 2018
Introduction. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel drug delivery system with superior pharmacological properties for treating peritoneal metastasis (PM).
Florian Kurtz, Florian Struller, Philipp Horvath, Wiebke Solass, Hans Bösmüller, Alfred Königsrainer, Marc A. Reymond   +6 more
doaj   +2 more sources

Hospitalization cost of Pressurized Intraperitoneal Aerosol chemotherapy (PIPAC)

European Journal of Surgical Oncology, 2023
International audienceIntroduction: Pressurized Intraperitoneal Aerosol chemotherapy (PIPAC) is a new surgical technique for the treatment of unresectable peritoneal carcinomatosis.
Faucheron, Jean-Luc, Fatah Tidadini, Ezanno, Anne-Cecile, Julio Abba, Chkair, Sihame, Quesada, Jean-Louis, Alison Foote, Adeline Aime, Jean-Luc Faucheron, Sihame Chkair, Foote, Alison, Chevallier, Thierry, Anne-Cecile Ezanno, Jean-Louis Quesada, Olivier Glehen, Arvieux, Catherine, Trilling, Bertrand, Thierry Chevallier, Glehen, Olivier, Tidadini, Fatah, Catherine Arvieux, Abba, Julio, Aime, Adeline, Bertrand Trilling   +23 more
core   +4 more sources

From palliation to cure: PIPAC for peritoneal malignancies

Minerva Medica, 2019
INTRODUCTION: Systemic chemotherapy offers poor control over peritoneal disease, maybe as a consequence of restricted drug availability within the abdominal cavity.
Attalla El Halabieh, M, Gallotta, V, Pacelli, F, Vita, E, Di Giorgio, A, Abatini, C, Vizzielli, G   +6 more
core   +4 more sources